IndexIQ Advisors’s Organon & Co OGN Stock Holding History

IndexIQ Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$35K	Buy	+1,015	New	+$34.7K	﹤0.01%	1169

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IndexIQ Advisors's OGN Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Organon & Co (OGN) in Q1 2022: 1,015 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #1169 among its holdings.

818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

IndexIQ Advisors held 1,015 shares of Organon & Co worth $35K as of Q1 2022.
Organon & Co was a new IndexIQ Advisors position in Q1 2022.
Organon & Co made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1169 holding.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.